Nobel prize winner Craig Mello joined the board of directors at Grove Instruments Inc., where he hopes to help make the first non-invasive blood glucose meter a reality.
Mello said he wanted to take a more active role in the Worcester, Mass.-based firm after two years as an advisor.
“Experiencing the 24-hour-a-day every day nature of this disease really makes you appreciate the tremendous potential benefit of Grove’s technology,” Mello, who has a child with the condition, said in prepared remarks. “I wanted more involvement – an opportunity to make a bigger impact on the success of the company and its technology.”
Sign up to get our free newsletters delivered straight to your inbox
Mello, the Blais University Chair of Molecular Medicine and co-director of the RNA Therapeutics Institute at the U-Mass. medicine school, won the 2006 Nobel Prize for medicine along with Andrew Fire for their research on RNA interference.
RNAi describes how living cells regulate gene activity. Since Mello and Fire delineated its mechanisms in 1998, via their close scrutiny of the C. elegans worm, it’s become an important tool for genetic researchers.
Grove Instruments is developing a blood glucometer designed to obviate the need for “finger-prick” blood testing for Type I diabetics. The technology uses an “optical bridge” to scan tissue and filter background tissue from the resulting image. The device can then detect the glucose levels in blood vessels, according to the company’s website.
For more recent hirings and firings, check out MassDevice’s compilation of the latest Personnel Moves
GE Healthcare taps Hausmann to head MRI segment
GE Healthcare tapped Richard Hausmann as the new general manager of the company’s magnetic resonance business, effective Jan. 1, 2012. Read more
InVivo names new CSO
Spinal cord surgeon Dr. Edward Wirth was named the new chief science officer at InVivo Therapeautics. Read more
Millstone Medical Outsourcing hires new VP
Fall River, Mass.-based Millstone Medical Outsourcing hired Thomas Lowe as vice president of business development. Read more
Yadav named chairman of SEDMA board
Founder & CEO of CardioMEMS Jay Yadav was elected chairman of the board of the Southeastern Medical Device Assn. Read more
Computer Vision Systems Lab appoints new CFO
Computer Vision Systems Laboratories Corp. named Thomas DiCicco to replace David Hostelley as its finance chief. Read more
Krishnan to join Intrexon as COO
Synthetic bioengineering company Intrexon Corp.
named Krish Krishnan as its new operations leader. Read more
Topica Pharmaceuticals appoints senior VP
Topica Pharmaceuticals Inc. appointed Amir Tavakkol as senior vice president of clinical development and operations. Read more
